4//SEC Filing
Hsieh Ming 4
Accession 0000950170-25-029433
CIK 0001674930other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 9:03 PM ET
Size
20.4 KB
Accession
0000950170-25-029433
Insider Transaction Report
Form 4
Hsieh Ming
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2025-02-25+11,280→ 711,195 total - Award
Common Stock
2025-02-25+17,820→ 729,015 total - Award
Common Stock
2025-02-25+37,197→ 766,212 total - Tax Payment
Common Stock
2025-02-25$16.29/sh−6,041$98,408→ 760,171 total - Tax Payment
Common Stock
2025-02-25$16.29/sh−9,543$155,455→ 750,628 total - Tax Payment
Common Stock
2025-02-25$16.29/sh−19,997$325,751→ 730,631 total - Award
Common Stock
2025-02-25+98,220→ 828,851 total - Tax Payment
Common Stock
2025-02-26$16.24/sh−11,773$191,194→ 817,078 total
Holdings
- 220,816(indirect: By Trust)
Common Stock
- 7,895,115(indirect: By Trust)
Common Stock
- 1,000(indirect: Uniform Transfer to Minor Account)
Common Stock
- 1,000(indirect: Uniform Transfer to Minor Account)
Common Stock
Footnotes (11)
- [F1]Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.
- [F10]Securities held by The Ming Hsieh Trust (the "Hsieh Trust"). Mr. Hsieh is the trustee of the Hsieh Trust and possesses the sole voting and dispositive power with respect to securities held by the Hsieh Trust.
- [F11]Shares held in a Uniform Transfers to Minor Act account for which Ming Hsieh acts as custodian and possesses the sole voting and dispositive power.
- [F2]Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023.
- [F3]Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024.
- [F4]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022.
- [F5]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023.
- [F6]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024.
- [F7]Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2025, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
- [F8]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
- [F9]Securities held by the Dynasty Trust. Mr. Hsieh is the grantor of the Dynasty Trust and he and his spouse, Eva Hsieh, and Jian Xie serve on the investment committee of the Dynasty Trust. Mr. Hsieh disclaims any beneficial interest except with respect to any pecuniary interest therein.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001302110
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 9:03 PM ET
- Size
- 20.4 KB